Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 310

1.

MicroRNA-133a regulates insulin-like growth factor-1 receptor expression and vascular smooth muscle cell proliferation in murine atherosclerosis.

Gao S, Wassler M, Zhang L, Li Y, Wang J, Zhang Y, Shelat H, Williams J, Geng YJ.

Atherosclerosis. 2014 Jan;232(1):171-9. doi: 10.1016/j.atherosclerosis.2013.11.029. Epub 2013 Nov 19.

2.
3.

MiR-133a modulates osteogenic differentiation of vascular smooth muscle cells.

Liao XB, Zhang ZY, Yuan K, Liu Y, Feng X, Cui RR, Hu YR, Yuan ZS, Gu L, Li SJ, Mao DA, Lu Q, Zhou XM, de Jesus Perez VA, Yuan LQ.

Endocrinology. 2013 Sep;154(9):3344-52. doi: 10.1210/en.2012-2236. Epub 2013 Jun 24.

PMID:
23798596
4.

Expression of insulin receptor (IR) A and B isoforms, IGF-IR, and IR/IGF-IR hybrid receptors in vascular smooth muscle cells and their role in cell migration in atherosclerosis.

Beneit N, Fernández-García CE, Martín-Ventura JL, Perdomo L, Escribano Ó, Michel JB, García-Gómez G, Fernández S, Díaz-Castroverde S, Egido J, Gómez-Hernández A, Benito M.

Cardiovasc Diabetol. 2016 Dec 1;15(1):161.

5.

Downregulation of miR-223 and miR-153 mediates mechanical stretch-stimulated proliferation of venous smooth muscle cells via activation of the insulin-like growth factor-1 receptor.

Song L, Duan P, Guo P, Li D, Li S, Xu Y, Zhou Q.

Arch Biochem Biophys. 2012 Dec 15;528(2):204-11. doi: 10.1016/j.abb.2012.08.015. Epub 2012 Oct 6.

PMID:
23046980
6.
7.

Insulin-like growth factor-1 receptor is regulated by microRNA-133 during skeletal myogenesis.

Huang MB, Xu H, Xie SJ, Zhou H, Qu LH.

PLoS One. 2011;6(12):e29173. doi: 10.1371/journal.pone.0029173. Epub 2011 Dec 15.

8.

Smooth muscle cell-specific insulin-like growth factor-1 overexpression in Apoe-/- mice does not alter atherosclerotic plaque burden but increases features of plaque stability.

Shai SY, Sukhanov S, Higashi Y, Vaughn C, Kelly J, Delafontaine P.

Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1916-24. doi: 10.1161/ATVBAHA.110.210831. Epub 2010 Jul 29.

9.

The microRNA miR-34c inhibits vascular smooth muscle cell proliferation and neointimal hyperplasia by targeting stem cell factor.

Choe N, Kwon JS, Kim YS, Eom GH, Ahn YK, Baik YH, Park HY, Kook H.

Cell Signal. 2015 Jun;27(6):1056-65. doi: 10.1016/j.cellsig.2014.12.022. Epub 2015 Feb 13.

PMID:
25683915
10.

Proprotein convertases regulate insulin-like growth factor 1-induced membrane-type 1 matrix metalloproteinase in VSMCs via endoproteolytic activation of the insulin-like growth factor-1 receptor.

Stawowy P, Kallisch H, Kilimnik A, Margeta C, Seidah NG, Chrétien M, Fleck E, Graf K.

Biochem Biophys Res Commun. 2004 Aug 27;321(3):531-8.

PMID:
15358140
11.

Insulin promotes vascular smooth muscle cell proliferation via microRNA-208-mediated downregulation of p21.

Zhang Y, Wang Y, Wang X, Zhang Y, Eisner GM, Asico LD, Jose PA, Zeng C.

J Hypertens. 2011 Aug;29(8):1560-8. doi: 10.1097/HJH.0b013e328348ef8e.

PMID:
21720271
12.

MicroRNA-99a inhibits insulin-induced proliferation, migration, dedifferentiation, and rapamycin resistance of vascular smooth muscle cells by inhibiting insulin-like growth factor-1 receptor and mammalian target of rapamycin.

Zhang ZW, Guo RW, Lv JL, Wang XM, Ye JS, Lu NH, Liang X, Yang LX.

Biochem Biophys Res Commun. 2017 Apr 29;486(2):414-422. doi: 10.1016/j.bbrc.2017.03.056. Epub 2017 Mar 15.

PMID:
28315335
13.

microRNA-18b modulates insulin-like growth factor-1 expression in deer antler cell proliferation by directly targeting its 3' untranslated region.

Hu W, Li M, Hu R, Li T, Meng X.

DNA Cell Biol. 2015 Apr;34(4):282-9. doi: 10.1089/dna.2014.2421. Epub 2015 Mar 10.

14.

Regulation of Vascular Smooth Muscle Cell Dysfunction Under Diabetic Conditions by miR-504.

Reddy MA, Das S, Zhuo C, Jin W, Wang M, Lanting L, Natarajan R.

Arterioscler Thromb Vasc Biol. 2016 May;36(5):864-73. doi: 10.1161/ATVBAHA.115.306770. Epub 2016 Mar 3.

15.

MiR-223 suppresses cell proliferation by targeting IGF-1R.

Jia CY, Li HH, Zhu XC, Dong YW, Fu D, Zhao QL, Wu W, Wu XZ.

PLoS One. 2011;6(11):e27008. doi: 10.1371/journal.pone.0027008. Epub 2011 Nov 2.

16.

miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice.

Ding W, Li J, Singh J, Alif R, Vazquez-Padron RI, Gomes SA, Hare JM, Shehadeh LA.

Cardiovasc Res. 2015 Apr 1;106(1):131-42. doi: 10.1093/cvr/cvv030. Epub 2015 Feb 12. Erratum in: Cardiovasc Res. 2016 Mar 1;109(3):373.

17.

The microRNA miR-132 targets Lrrfip1 to block vascular smooth muscle cell proliferation and neointimal hyperplasia.

Choe N, Kwon JS, Kim JR, Eom GH, Kim Y, Nam KI, Ahn Y, Kee HJ, Kook H.

Atherosclerosis. 2013 Aug;229(2):348-55. doi: 10.1016/j.atherosclerosis.2013.05.009. Epub 2013 May 20.

PMID:
23880186
18.

IGF-1 has plaque-stabilizing effects in atherosclerosis by altering vascular smooth muscle cell phenotype.

von der Thüsen JH, Borensztajn KS, Moimas S, van Heiningen S, Teeling P, van Berkel TJ, Biessen EA.

Am J Pathol. 2011 Feb;178(2):924-34. doi: 10.1016/j.ajpath.2010.10.007.

19.

miR-99b suppresses IGF-1R expression and contributes to inhibition of cell proliferation in human epidermal keratinocytes.

Li J, Fang R, Gong Q, Wang J.

Biomed Pharmacother. 2015 Oct;75:159-64. doi: 10.1016/j.biopha.2015.07.013. Epub 2015 Aug 19.

PMID:
26297545
20.

Supplemental Content

Support Center